News

Using Neuromodulation to Treat Premature Ejaculation

Morari Medical is developing a wearable device that could make premature ejaculation a thing of the past. The company debuted a prototype of the technology during the Consumer Electronics Show earlier this month.

BioCardia Fills in a Key Piece of CardiaAmp Puzzle with New Clearance

The San Carlos, CA-based company has received a nod from FDA for the Morph DNA deflectable guide catheter, which is used to guide the Helix Biotherapeutic Delivery System during CardiAMP cell therapy delivery in the heart.

Medtech in a Minute: Bigfoot Has Friends in High Places, DexCom Shines at JPM, and More

Pressed for time? Here's the medtech news you need most, in one minute or less.

How Medtronic Is 'Igniting Women to Lead'

Medtronic is one of three companies selected to win the 2020 Catalyst Award. The honor recognizes corporations that have made it a priority to foster an inclusive workplace where women can advance.

Team Up to Advance Bioelectronics

A new alliance seeks to generate interest and awareness of the growing bioelectronic medicine sector.

Researchers Turn to Medtech to Reduce Pain and Swelling from Best-Selling Drugs

A Purdue University team created a technology that could help drug companies create new formulations and injection devices of biologics.

DexCom's Preliminary Numbers Shine at J.P. Morgan

The San Diego, CA-based company presented strong preliminary financial results and gave an update on its highly anticipated G7 Continuous Glucose Monitor (CGM) sensor during the 38th annual J.P. Morgan Healthcare Conference.

Medtronic Wins CE Mark for Rechargeable Sacral Neuromodulation Tech

The regulatory milestone marks a significant gain in the company's ongoing battle for market share against newcomer Axonics.

Abbott Kicks in for Bigfoot's $45M Financing

The company is on track to submit its Bigfoot Unity diabetes management program for FDA clearance in 2020, and is targeting a product launch by the end of the year.

Allow Me to Reintroduce Myself: Hologic Gets Back to Basics After Cynosure

The Marlborough, MA-based company presented its plan for success at the 38th annual J.P. Morgan Healthcare Conference, announcing it would pursue more tuck-in deals and invest in share buybacks. The plans come a few weeks after Hologic’s divested the Cynosure medical aesthetics business, which had been underperforming.